CYP2C9*3 gene variant contributes independently to glycaemic control in patients with type 2 diabetes treated with glibenclamide
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CYP2C9*3
gene variant contributes independently to glycaemic control in patients with type 2 diabetes treated with glibenclamide
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-05-27
DOI
10.1111/jcpt.12710
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genetic variations in TCF7L2 influence therapeutic response to sulfonylureas in Indian diabetics
- (2016) Dipali Dhawan et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Combined Influence of Genetic Variants and Gene-gene Interaction on Sulfonylurea Efficacy in Type 2 Diabetic Patients
- (2016) Q. Ren et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Combination of recreational soccer and caloric restricted diet reduces markers of protein catabolism and cardiovascular risk in patients with type 2 diabetes
- (2016) Maysa Vieira de Sousa et al. Journal of Nutrition Health & Aging
- Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association
- (2015) Caroline S. Fox et al. DIABETES CARE
- CYP2C9, KCNJ11 and ABCC8 polymorphisms and the response to sulphonylurea treatment in type 2 diabetes patients
- (2014) Jasna Klen et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- TCF7L2 is a master regulator of insulin production and processing
- (2014) Yuedan Zhou et al. HUMAN MOLECULAR GENETICS
- Is Glucose Control Important for Prevention of Cardiovascular Disease in Diabetes?
- (2013) E. Mannucci et al. DIABETES CARE
- Global estimates of diabetes prevalence for 2013 and projections for 2035
- (2013) L. Guariguata et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Estimating the effect of sulfonylurea on HbA1c in diabetes: a systematic review and meta-analysis
- (2013) J. A. Hirst et al. DIABETOLOGIA
- Allele frequency distribution of CYP2C9*2 and CYP2C9*3 polymorphisms in six Mexican populations
- (2013) Osvaldo D. Castelán-Martínez et al. GENE
- Chronic Hyperglycemia and Glucose Toxicity: Pathology and Clinical Sequelae
- (2013) Carlos Campos POSTGRADUATE MEDICINE
- Association betweenTCF7L2Genotype and Glycemic Control in Diabetic Patients Treated with Gliclazide
- (2013) Martin Javorský et al. International Journal of Endocrinology
- TCF7L2 genetic variants modulate the effect of dietary fat intake on changes in body composition during a weight-loss intervention
- (2012) Josiemer Mattei et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Patterns of Medication Initiation in Newly Diagnosed Diabetes Mellitus: Quality and Cost Implications
- (2012) Nihar R. Desai et al. AMERICAN JOURNAL OF MEDICINE
- TCF7L2 and therapeutic response to sulfonylureas in patients with type 2 diabetes
- (2011) Andreas Holstein et al. BMC Medical Genetics
- Influence of CYP2C9 gene polymorphisms on response to glibenclamide in type 2 diabetes mellitus patients
- (2011) A. Surendiran et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- KCNJ11 gene E23K variant and therapeutic response to sulfonylureas
- (2011) Martin Javorsky et al. European Journal of Internal Medicine
- Pharmacogenomic analysis of ATP-sensitive potassium channels coexpressing the common type 2 diabetes risk variants E23K and S1369A
- (2011) Veronica Y. Lang et al. Pharmacogenetics and Genomics
- Effect of sulphonylurea treatment on glycaemic control is related to TCF7L2 genotype in patients with type 2 diabetes
- (2010) Z. Schroner et al. DIABETES OBESITY & METABOLISM
- Metabolic Control in Type 2 Diabetes Is Associated with Sulfonylurea Receptor-1 (SUR-1) but Not with KCNJ11 Polymorphisms
- (2009) Nora Nikolac et al. ARCHIVES OF MEDICAL RESEARCH
- Loss-of-Function CYP2C9 Variants Improve Therapeutic Response to Sulfonylureas in Type 2 Diabetes: A Go-DARTS Study
- (2009) K Zhou et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search